A Proof-of-Concept Study of AC-201 to Prevent Gout Flares

NCT01712204 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout Flares

Interventions

DRUG: Placebo
DRUG: AC-201
DRUG: Febuxostat

Sponsor

TWi Biotechnology, Inc.